참고문헌
- Seino S and Shibasaki T (2005) PKA-dependent and pka-independent pathways for cAMP-regulated exocytosis. Physiol Rev 85, 1303-1342 https://doi.org/10.1152/physrev.00001.2005
- Takahashi H, Shibasaki T, Park JH et al (2015) Role of Epac2A/Rap1 signaling in interplay between incretin and sulfonylurea in insulin secretion. Diabetes 64, 1262-1272 https://doi.org/10.2337/db14-0576
- Schmidt M, Dekker FJ and Maarsingh H (2013) Exchange protein directly activated by cAMP (epac): a multidomain cAMP mediator in the regulation of diverse biological functions. Pharmacol Rev 65, 670-709 https://doi.org/10.1124/pr.110.003707
- Hwang M, Go Y, Park JH et al (2017) Epac2a-null mice exhibit obesity-prone nature more susceptible to leptin resistance. Int J Obes 41, 279-288 https://doi.org/10.1038/ijo.2016.208
- Huxing C, Miguel L and Kamal R (2017) The cellular and molecular bases of leptin and ghrelin resistance in obesity. Nat Rev Endocrinol 13, 338-351 https://doi.org/10.1038/nrendo.2016.222
- Morgan DA, Thedens DR, Weiss R and Rahmouni K (2008) Mechanisms mediating renal sympathetic activation to leptin in obesity. Am J Physiol Regul Integr Comp Physiol 295, R1730-R1736 https://doi.org/10.1152/ajpregu.90324.2008
- Caro JF, Kolaczynski JW, Nyce MR et al (1996) Decreased cerebrospinal-fluid/serum leptin ratio in obesity: a possible mechanism for leptin resistance. Lancet 348, 159-161 https://doi.org/10.1016/S0140-6736(96)03173-X
- Banks WA (2001) Leptin transport across the blood-brain barrier: implications for the cause and treatment of obesity. Curr Pharm Des 7, 125-133 https://doi.org/10.2174/1381612013398310
- Magni P, Liuzzi A, Ruscica M et al (2005) Free and bound plasma leptin in normal weight and obese men and women: relationship with body composition, resting energy expenditure, insulin sensitivity, lipid profile and macronutrient preference. Clin Endocrinol 62, 189-196 https://doi.org/10.1111/j.1365-2265.2005.02195.x
- Houseknecht KL, Mantzoros CS, Kuliawat R, Hadro E, Flier JS and Kahn BB (1996) Evidence for leptin binding to proteins in serum of rodents and humans: modulation with obesity. Diabetes 45, 1638-1643 https://doi.org/10.2337/diab.45.11.1638
- Schwartz MW, Peskind E, Raskind M, Boyko EJ and Porte D Jr (1996) Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med 2, 589-593 https://doi.org/10.1038/nm0596-589
- Nickki O, Parinaz M, Belen R et al (2015) Diet-induced obese mice retain endogenous leptin action. Cell Metab 6, 877-882
- Haynes WG, Morgann DA, Djalali A et al (1999) Interactions between the melanocortin system and leptin in control of sympathetic nerve traffic. Hypertension 33, 542-547 https://doi.org/10.1161/01.HYP.33.1.542
- Cone RD (2005) Anatomy and regulation of the central melanocortin system. Nat Neurosci 8, 571-578 https://doi.org/10.1038/nn1455
- Cowley MA, Smart JL, Rubinstein M et al (2001) Leptin activates anorexingenic POMC neurons through a neural network in the arcuate nucleus. Nature 411, 480-484 https://doi.org/10.1038/35078085
- Simonds SE, Pryor JT, Ravussin E et al (2014) Leptin mediates the increase in blood pressure associated with obesity. Cell 159, 1404-1416 https://doi.org/10.1016/j.cell.2014.10.058
- Siegrist-Kaiser CA, Pauli V, Juge-Aubry CE et al (1997) Direct effects of leptin on brown and white adipose tissue. J Clin Invest 100, 2858-2864 https://doi.org/10.1172/JCI119834
- Maroni P, Bendinelli R, Piccoletti R (2003) Early intracellular events induced by in vivo leptin treatment in mouse skeletal muscle. Mol Cell Endocrinol 201, 109-121 https://doi.org/10.1016/S0303-7207(02)00427-6
- Gema F (2006) Intracellular signalling pathways activated by leptin. Biochem J 393, 7-20 https://doi.org/10.1042/BJ20051578
- Bai Y, Zhang SY, Kim KS, Lee JK and Kim KH (1996) Obese gene expression alters the ability of 30A5 preadipocytes to respond to lipogenic hormones. J Biol Chem 271, 13939-13942 https://doi.org/10.1074/jbc.271.24.13939
- Bartness TJ, Vaughan CH and CK Song (2010) Sympathetic and sensory innervation of brown adipose tissue. Int J Obes (Lond) 34, S36-S42 https://doi.org/10.1038/ijo.2010.182
- Enriori PJ, Sinnayah P, Simonds SE, Rudaz CG and Cowley MA (2011) Leptin action in the dorsomedial hypothalamus increases sympathetic tone to brown adipose tissue in spite of systemic leptin resistance. J Neurosci 31, 12189-12197 https://doi.org/10.1523/JNEUROSCI.2336-11.2011
- Hwa JJ, Fawzi AB, Graziano MP et al (1997) Leptin increase energy expenditure and selectively promotes fat metabolism in ob/ob mice. Am J Physiol 272, R1204-1209
- Scott MM, Lachey JL, Sternson SM et al (2009) Leptin targets in the mouse brain. J Comp Neurol 514, 518-532 https://doi.org/10.1002/cne.22025
- Margetic S, Gazzola C, Pegg GG and Hill RA (2002) Leptin: a review of its peripheral actions and interactions. Int J Obes Rel Metab Disord 26, 1407-1433 https://doi.org/10.1038/sj.ijo.0802142
- Sainz N, Rodriguez A, Catalan V, Becerril S and Ramirez B (2009) Leptin administration favors muscle mass accretion by decreasing fox03a and Increasing PGC-1a in ob/ob mice. PLoS One 4, e6808 https://doi.org/10.1371/journal.pone.0006808
- Hamrick MW, Pennington C, Newton D, Xie D and Isales CM (2004) Leptin deficiency produces contrasting phenotypes in bones of the limb and spine. Bone 34, 376-383 https://doi.org/10.1016/j.bone.2003.11.020
- Pansters NA, Langen RC, Wouters E and Schols AM (2012) Synergistic stimulation of myogenesis by glucocorticoid and IGF-I signaling. J Appl Phys 114, 1329-1339
- Allen D, Clearly A, Speaker K et al (2008) Myostatin, activin receptor IIB, and follistatin-like-3 gene are altered in adipose tissue and skeletal muscle of obese mice. Am J Physiol Endocrinol Metab 294, E918-E927 https://doi.org/10.1152/ajpendo.00798.2007
- Hamrick MW, Herberg S, Arounleut P et al (2010) The adipokine leptin increases skeletal muscle mass and significantly alters skeletal muscle miRNA expression profile in aged mice. Biochem Biophys Res Commun 400, 379-383 https://doi.org/10.1016/j.bbrc.2010.08.079
-
Lynch GS and Ryall JG (2008) Role of
$\beta$ -adrenoceptor signaling in skeletal muscle: implication for muscle wasting and disease. Physiol Rev 88, 729-767 https://doi.org/10.1152/physrev.00028.2007 - Maroni P, Bendinelli P and Piccoletti R (2003) Early Intracellular events induced by in vivo leptin treatment in mouse skeletal muscle. Mol Cell Endocrinol 201, 109-121 https://doi.org/10.1016/S0303-7207(02)00427-6
- Hasselgren PO, Wray C and Mammen J (2002) Molecular regulation of muscle cachexia: it may be more than the proteasome. Biochem Biophys Res Commun 290, 1-10 https://doi.org/10.1006/bbrc.2001.5849
- Romanick M, Thompson LV and Brown-Borg HM (2013) Murine models of atrophy, cachexia, and sarcopenia in skeletal muscle. Biochim Biophys Acta 1832, 1410-1420 https://doi.org/10.1016/j.bbadis.2013.03.011